Read + Share
Erwin P, Donington J. Oncologic end points and implication of trial design in the era of immunotherapy
for resectable non-small cell lung cancer. J Thorac Cardiovasc Surg 2022 Nov 4:S0022-5223(22)01170.
PMID: 36528434
|
 |
|
Erwin P, Donington J. Oncologic end points and implication of trial design in the era of immunotherapy
for resectable non-small cell lung cancer. J Thorac Cardiovasc Surg 2022 Nov 4:S0022-5223(22)01170.
PMID: 36528434
|
|
|
|